In the present study, we demonstrated that MUM256 EA reduced the proliferation of colon cancer cells by arresting cells at G1 and G2 phases through the modulation of cell-cycle regulatory proteins including p21, cyclin B1, CDK2, CDK4 and cdc25A phosphatase. Here, CCNB1 is linked to malignant colon neoplasm.